GlassScriptPhysician profile
Fernando Fernandez
NPI 1003043464
$7,117.90
in general payments reported to CMS, 2019-2025
20 companies · $1,924 in 2025
The $1,924 reported for 2025 was more than what 94% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $1,378 · 2021: $1,625 · 2022: $551 · 2023: $476 · 2024: $1,029 · 2025: $1,924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,800 · Food and Beverage: $1,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,799.62 |
| Food and Beverage | $1,628.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $5,570.88 | 2020-2025 | |
| Stryker Corporation | $242.37 | 2019-2025 | Augment Injectable, Prostep Mica |
| Ossio INC | $210.13 | 2024 | |
| Sanara Medtech INC. | $204.90 | 2021-2022 | |
| Bioventus LLC | $167.47 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $124.53 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Extremity Medical | $98.92 | 2023 | Io Fix |
| Merck Sharp & Dohme LLC | $87.92 | 2019 | |
| Voom Medical Devices, INC. | $49.13 | 2025 | Revcon |
| Biotissue Holdings INC. | $48.78 | 2025 | |
| Polynovo North America LLC | $44.96 | 2024 | Novosorb Btm |
| Grt US Holding, INC. | $42.20 | 2021 | |
| Novus Surgical Consultants | $37.83 | 2025 | |
| Fidia Pharma USA INC. | $37.78 | 2024-2025 | |
| Innovation Technologies INC | $34.71 | 2024 | Irrisept |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $27.68 | 2022 | |
| Ibsa Pharma INC. | $24.18 | 2024 | Licart, Tirosint, Flector |
| Organogenesis INC. | $23.29 | 2025 | Simplimax |
| Nevro Corp. | $20.20 | 2020 | |
| Paratek Pharmaceuticals, INC. | $20.04 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.